E to E Transportation Infrastructure IPO vs Rednex Pharmaceuticals IPO

Comparison between E to E Transportation Infrastructure IPO and Rednex Pharmaceuticals IPO.

IPO Details

E to E Transportation Infrastructure IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Rednex Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.

Issue Size and Price

The total issue size of E to E Transportation Infrastructure IPO is up to ₹79.97 Cr whereas the issue size of the Rednex Pharmaceuticals IPO is up to ₹0.00 Cr. The final issue price of E to E Transportation Infrastructure IPO is ₹174.00 per share and of Rednex Pharmaceuticals IPO is .

 E to E Transportation Infrastructure IPORednex Pharmaceuticals IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹164.00 per share
Issue Price (Upper)₹174.00 per share
Issue Price (Final)₹174.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size800 shares
Fresh Issue Size45,96,000 shares27,36,000 shares
Fresh Issue Size (Amount)up to ₹79.97 Crup to ₹0.00 Cr
OFS Issue Size0 shares0 shares
OFS Issue Size (Amount)up to ₹0.00 Crup to ₹0.00 Cr
Issue Size Total45,96,000 shares27,36,000 shares
Issue Size Total (Amount)up to ₹79.97 Crup to ₹0.00 Cr

IPO Timetable

E to E Transportation Infrastructure IPO opens on Dec 26, 2025, while Rednex Pharmaceuticals IPO opens on . The closing date of E to E Transportation Infrastructure IPO and Rednex Pharmaceuticals IPO is Dec 30, 2025, and , respectively.

Financials & KPIs

E to E Transportation Infrastructure IPO P/E ratio is 15.44, as compared to Rednex Pharmaceuticals IPO P/E ratio of .

 E to E Transportation Infrastructure IPORednex Pharmaceuticals IPO
Financials

Company Financials (Restated)

E to E Transportation Infrastructure Ltd.'s revenue increased by 47% and profit after tax (PAT) rose by 36% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Sep 202531 Mar 202531 Mar 202431 Mar 2023
Assets310.84295.44200.89145.16
Total Income112.78253.82172.50135.70
Profit After Tax-7.4913.9910.268.15
EBITDA-3.8826.5718.3413.28
NET Worth108.70116.0566.8657.15
Reserves and Surplus96.28115.6866.6756.95
Total Borrowing113.5166.1861.1843.11
Amount in ₹ Crore

Company Financials (Restated)

Rednex Pharmaceuticals Ltd.'s revenue increased by 88% and profit after tax (PAT) rose by 120% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets50.1232.7517.10
Total Income46.1224.481.72
Profit After Tax4.261.93-0.93
EBITDA9.214.57-0.69
NET Worth9.475.213.27
Reserves and Surplus5.220.96-0.98
Total Borrowing19.1419.2210.35
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)45.19100
Promoter Shareholding (Post-Issue)32.51
P/E Ratio15.44
Market Cap₹300.28 Cr.
ROE15.7258.10
ROCE15.6923.29
Debt/Equity0.572.02
EPS₹11.27
RoNW12.3945.02

Shares Offered

In the E to E Transportation Infrastructure IPO Retail Individual Investors (RII) are offered 16,09,600 shares while in Rednex Pharmaceuticals IPO retail investors are offered 16,09,600 shares. Qualified Institutional Buyers (QIB) are offered 9,19,200 shares in E to E Transportation Infrastructure IPO and 0 shares in Rednex Pharmaceuticals IPO.

 E to E Transportation Infrastructure IPORednex Pharmaceuticals IPO
Anchor Investor Reservation13,77,600 shares0 shares
Market Maker Reservation2,44,000 shares0 shares
QIB9,19,200 shares0 shares
NII6,89,600 shares0 shares
RII16,09,600 shares0 shares
Employee0 shares0 shares
Others
Total45,96,000 shares0 shares

Bids Received (Subscription)

E to E Transportation Infrastructure IPO subscribed 368.73x in total, whereas Rednex Pharmaceuticals IPO subscribed .

Compare with others

Compare: